News Conference News AHA 2020 Empagliflozin Improves Cardiac Function, Exercise Capacity in Nondiabetic HFrEF Todd Neale November 16, 2020
News Conference News AHA 2020 Modest Gains With Omecamtiv Mecarbil in Chronic HFrEF: GALACTIC-HF Todd Neale November 13, 2020
News Features Playing With Heart: Returning Kids Safely to Sport in the COVID-19 Era Todd Neale November 02, 2020
News Conference News HFSA 2020 Splanchnic Nerve Ablation Improves HFpEF Symptoms, QoL in FIH Study L.A. McKeown October 12, 2020
News Daily News TAVR Delays During Pandemic’s Peak Led to Hospitalizations, Deaths Michael O'Riordan September 30, 2020
News Daily News Open Letter Calls on CV Societies to Discourage CMR After Mild COVID-19 Shelley Wood September 15, 2020
News Conference News ESC 2020 EXPLORER-HCM: Mavacamten Improves Exercise Capacity and Functional Class Michael O'Riordan August 29, 2020
News Daily News Signs of Cardiac Damage Even in Younger, Nonhospitalized COVID-19 Patients Shelley Wood July 29, 2020
News Daily News Higher Risk of HF After ACS for Women Previously on Beta-blockers Michael O'Riordan July 16, 2020
News Daily News Mavacamten Successful in Obstructive Hypertrophic Cardiomyopathy: EXPLORER-HCM Shelley Wood May 11, 2020
News Daily News Patient-Level Data Strengthen Rosiglitazone-CV Link: Meta-analysis Caitlin E. Cox February 07, 2020